Bustamante, Jayber C.
HRN: 20-77-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
CEFTRIAXONE 1G (VIAL)
05/31/2023
06/07/2023
IV
1g
Q24h
Age With Moderate Dhn, Uti
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes